Discontinued — last reported Q3 '25

Equity

Non-Controlling Interests

Roivant Sciences Non-Controlling Interests increased by 8.5% to $765.04M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 53.1%, from $499.59M to $765.04M. Over 5 years (FY 2020 to FY 2025), Non-Controlling Interests shows an upward trend with a 25.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ3 2025

How to read this metric

An increase suggests the company has expanded its consolidated operations through partially-owned subsidiaries, while a decrease may indicate buyouts of minority stakes.

Detailed definition

This represents the portion of equity in a subsidiary not attributable, directly or indirectly, to the parent company. I...

Peer comparison

Common in large conglomerates or companies with complex joint venture structures; peers often report this as a small fraction of total equity.

Metric ID: noncontrolling_interests

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$234.22M$390.39M$381.54M$382.00M$371.28M$353.55M$471.62M$449.82M$423.41M$377.10M$494.82M$479.95M$459.98M$427.09M$346.50M$499.59M$470.27M$443.13M$704.97M$765.04M
QoQ Change+66.7%-2.3%+0.1%-2.8%-4.8%+33.4%-4.6%-5.9%-10.9%+31.2%-3.0%-4.2%-7.2%-18.9%+44.2%-5.9%-5.8%+59.1%+8.5%
YoY Change+58.5%-9.4%+23.6%+17.8%+14.0%+6.7%+4.9%+6.7%+8.6%+13.3%-30.0%+4.1%+2.2%+3.8%+103.5%+53.1%
Range$234.22M$765.04M
CAGR+28.3%
Avg YoY Growth+17.6%
Median YoY Growth+7.7%
Current Streak2 quarters growth

Frequently Asked Questions

What is Roivant Sciences's non-controlling interests?
Roivant Sciences (ROIV) reported non-controlling interests of $765.04M in Q1 2026.
How has Roivant Sciences's non-controlling interests changed year-over-year?
Roivant Sciences's non-controlling interests increased by 53.1% year-over-year, from $499.59M to $765.04M.
What is the long-term trend for Roivant Sciences's non-controlling interests?
Over 5 years (2020 to 2025), Roivant Sciences's non-controlling interests has grown at a 25.9% compound annual growth rate (CAGR), from $241.73M to $765.04M.
What does non-controlling interests mean?
The portion of a subsidiary's equity owned by outside parties rather than the parent company.